These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24360556)

  • 21. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
    Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ
    Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of NAD+ dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle.
    Michelet JF; Colombe L; Gautier B; Gaillard O; Benech F; Pereira R; Boulle C; Dalko-Csiba M; Rozot R; Neuwels M; Bernard BA
    Exp Dermatol; 2008 Oct; 17(10):821-8. PubMed ID: 18328086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins.
    Sun CC; Zhou ZQ; Yang D; Chen ZL; Zhou YY; Wen W; Feng C; Zheng L; Peng XY; Tang CF
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108176. PubMed ID: 34655851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic studies on 15-hydroxyprostaglandin dehydrogenase from human placenta.
    Schlegel W; Greep RO
    Adv Prostaglandin Thromboxane Res; 1976; 1():159-62. PubMed ID: 187034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel prostaglandin dehydrogenase in rat skin.
    Fincham N; Camp R
    Biochem J; 1983 Apr; 212(1):129-34. PubMed ID: 6575778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase.
    Dai L; Perera DS; King DW; Southwell BR; Burcher E; Liu L
    J Pharmacol Exp Ther; 2012 Jan; 340(1):27-36. PubMed ID: 21957267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 15-hydroxyprostaglandin dehydrogenase inhibitor on wound healing.
    Seo SY; Han SI; Bae CS; Cho H; Lim SC
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jun; 97():35-41. PubMed ID: 25899574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue.
    Westbrook C; Lin YM; Jarabak J
    Biochem Biophys Res Commun; 1977 Jun; 76(3):943-9. PubMed ID: 20082
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoclonal antibodies that inhibit the enzyme activity of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
    Tai CL; Mak OT; Arai T; Tai HH
    Biochem J; 1990 Apr; 267(1):75-8. PubMed ID: 1691637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.
    Cho H; Huang L; Hamza A; Gao D; Zhan CG; Tai HH
    Bioorg Med Chem; 2006 Oct; 14(19):6486-91. PubMed ID: 16828555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of pulmonary NAD+-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein.
    Liu Y; Tai HH
    Biochem Pharmacol; 1985 Dec; 34(24):4275-8. PubMed ID: 4074386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous inhibitor of 15-hydroxyprostaglandin dehydrogenase in human placenta.
    Nagai K; Mibe M; Mori N
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):157-61. PubMed ID: 2622970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and SAR of thiazolidinedione derivatives as 15-PGDH inhibitors.
    Wu Y; Tai HH; Cho H
    Bioorg Med Chem; 2010 Feb; 18(4):1428-33. PubMed ID: 20122835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous inhibitors of human placental prostaglandin dehydrogenase.
    Mibe M; Nagai K; Oshige T; Mori N
    Prostaglandins Leukot Essent Fatty Acids; 1992 Jul; 46(3):241-5. PubMed ID: 1508959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Threonine 11 of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase may interact with NAD(+) during catalysis.
    Cho H; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(5-6):505-9. PubMed ID: 12144871
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Karna S
    Pharmacogn Mag; 2017 Jan; 13(Suppl 1):S122-S126. PubMed ID: 28479736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue.
    Bärnthaler T; Theiler A; Zabini D; Trautmann S; Stacher-Priehse E; Lanz I; Klepetko W; Sinn K; Flick H; Scheidl S; Thomas D; Olschewski H; Kwapiszewska G; Schuligoi R; Heinemann A
    J Allergy Clin Immunol; 2020 Mar; 145(3):818-833.e11. PubMed ID: 31812575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placental 15-hydroxyprostaglandin dehydrogenase binding site requirements.
    Thaler-Dao H; Saintot M; Baudin G; Descomps B; Crastes de Paulet A
    Adv Prostaglandin Thromboxane Res; 1976; 1():177-82. PubMed ID: 187036
    [No Abstract]   [Full Text] [Related]  

  • 40. Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.
    Young AL; Chalmers CR; Hawcroft G; Perry SL; Treanor D; Toogood GJ; Jones PF; Hull MA
    BMC Cancer; 2013 Feb; 13():92. PubMed ID: 23442768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.